Patents by Inventor Sabine Fürtinger

Sabine Fürtinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable aqueous formulation for growth hormone
    Patent number: 11446381
    Abstract: The present invention is related to a pharmaceutically acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein, wherein the concentration ratio between the biopharmaceutical protein and the neutral salt is in the range of ?0.7 and ?5.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: September 20, 2022
    Assignee: SANDOZ AG
    Inventors: Bernt Pragl, Sabine Fuertinger
  • STABLE AQUEOUS FORMULATION FOR GROWTH HORMONE
    Publication number: 20180256722
    Abstract: The present invention is related to a pharmaceutically acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein, wherein the concentration ratio between the biopharmaceutical protein and the neutral salt is in the range of ?0.7 and ?5.
    Type: Application
    Filed: March 6, 2018
    Publication date: September 13, 2018
    Inventors: Bernt Pragl, Sabine Fuertinger
  • Pharmaceutical formulation comprising a biopharmaceutical drug
    Patent number: 9480743
    Abstract: The present invention is related to a pharmaceutical formulation comprising a biopharmaceutical drug, said composition further comprising at least one mono- or dicarboxylic acid with a backbone of 2-6 C-Atoms, or at least one salt thereof.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: November 1, 2016
    Assignee: Hexal AG
    Inventors: Martina Danek-Bulius, Britta Deutel, Sabine Fürtinger, Bernt Pragl, Drago Kuzman
  • Stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc
    Patent number: 9453067
    Abstract: The present invention relates to stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc comprising different buffer systems and stabilizers. In particular, it could be demonstrated that the physical stability of TNFR:Fc is significantly improved by using a citrate buffer system and lysine as stabilizer.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: September 27, 2016
    Assignee: Sandoz AG
    Inventors: Britta Deutel, Thomas Lauber, Sabine Fuertinger
  • Stable aqueous G-CSF formulations
    Patent number: 9119789
    Abstract: The invention relates to stable glutamate-buffered G-CSF formulations having a pH of from 3.5 to 4.8. The invention further concerns lyophilisates and powders obtainable from such formulations, and to pharmaceutical kits containing such lyophilisates and powders.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: September 1, 2015
    Assignee: SANDOZ AG
    Inventors: Sabine Fürtinger, Heinrich Matous
  • AQUEOUS FORMULATION COMPRISING AT LEAST A NEUTRAL SALT AND A BIOPHARMACEUTICAL PROTEIN
    Publication number: 20140194356
    Abstract: The present invention is related to a pharmaceutically acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein, wherein the concentration ratio between the biopharmaceutical protein and the neutral salt is in the range of ?0.7 and ?5.
    Type: Application
    Filed: July 25, 2012
    Publication date: July 10, 2014
    Applicant: SANDOZ AG
    Inventors: Bernt Pragl, Sabine Fuertinger
  • STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc
    Publication number: 20140186351
    Abstract: The present invention relates to stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc comprising different buffer systems and stabilizers. In particular, it could be demonstrated that the physical stability of TNFR:Fc is significantly improved by using a citrate buffer system and lysine as stabilizer.
    Type: Application
    Filed: April 19, 2012
    Publication date: July 3, 2014
    Applicant: SENDOZ AG
    Inventors: Deutel Britta, Thomas Lauber, Sabine Fuertinger
  • STABLE AQUEOUS G-CSF FORMULATIONS
    Publication number: 20100104627
    Abstract: The invention relates to stable glutamate-buffered G-CSF formulations having a pH of from 3.5 to 4.8. The invention further concerns lyophilisates and powders obtainable from such formulations, and to pharmaceutical kits containing such lyophilisates and powders.
    Type: Application
    Filed: April 4, 2008
    Publication date: April 29, 2010
    Inventors: Sabine Fürtinger, Heinrich Matous